Manabu Horii Selected Research

Infarction (Infarctions)

8/2007	Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction.
4/2006	Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manabu Horii Research Topics

Disease

9	Myocardial Infarction 06/2013 - 04/2006
7	Heart Failure 01/2018 - 09/2004
3	Acute Coronary Syndrome 01/2023 - 01/2011
3	Stroke (Strokes) 01/2023 - 06/2013
3	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2009
2	Chronic Renal Insufficiency 01/2022 - 06/2013
2	Fabry Disease (Fabry's Disease) 01/2019 - 12/2018
2	Hyperplasia 10/2008 - 09/2006
2	Infarction (Infarctions) 08/2007 - 04/2006
1	Supraventricular Tachycardia 01/2023
1	Bradycardia 01/2023
1	Ventricular Tachycardia 01/2023
1	Sarcopenia 01/2021
1	Takotsubo Cardiomyopathy 01/2018
1	Pulmonary Hypertension 01/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 06/2015
1	Ischemic Stroke 04/2015
1	Brain Infarction 04/2015
1	Necrosis 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013
1	Fever (Fevers) 03/2012
1	Lacerations 01/2012
1	Pathologic Constriction (Stenosis) 01/2012
1	Hypertrophy 04/2010
1	Renal Insufficiency (Renal Failure) 12/2009
1	Atherosclerosis 12/2009
1	Thrombosis (Thrombus) 12/2009
1	Stable Angina 10/2008
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2008
1	Neointima 09/2006
1	Neoplasms (Cancer) 07/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2006

Drug/Important Bio-Agent (IBA)

5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 04/2006
3	Tyrosine (L-Tyrosine)FDA Link 01/2013 - 12/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2013
2	Peptides (Polypeptides)IBA 06/2013 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 06/2013 - 12/2009
2	LipidsIBA 01/2012 - 01/2011
2	CytokinesIBA 12/2009 - 10/2008
2	Natriuretic PeptidesIBA 07/2007 - 09/2004
2	AldosteroneIBA 07/2006 - 01/2006
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	GlycosphingolipidsIBA 01/2019
1	GalactosidasesIBA 12/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	PlasminogenIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	DiureticsIBA 06/2015
1	Tolvaptan FDA Link 06/2015
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2015
1	Angiotensin Receptor AntagonistsIBA 04/2015
1	C-Reactive ProteinIBA 03/2012
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2010
1	ApolipoproteinsIBA 12/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009
1	Sirolimus (Rapamycin)FDA Link 10/2008
1	MetalsIBA 10/2008
1	3-Iodobenzylguanidine (Iobenguane)IBA 09/2008
1	Proteins (Proteins, Gene)FDA Link 09/2008
1	von Willebrand FactorIBA 09/2008
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 08/2007
1	Atrial Natriuretic Factor (ANF)IBA 07/2007
1	InterleukinsIBA 09/2006
1	Pentoxifylline (Trental)FDA LinkGeneric 09/2006
1	Messenger RNA (mRNA)IBA 09/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2006
1	efonidipineIBA 07/2006
1	Angiotensin IIIBA 07/2006
1	Nifedipine (Adalat)FDA LinkGeneric 07/2006
1	RNA (Ribonucleic Acid)IBA 04/2006
1	salicylhydroxamic acid (SHAM)IBA 04/2006

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2009
2	Percutaneous Coronary Intervention 01/2012 - 09/2006
2	Stents 12/2009 - 10/2008
1	Patient Readmission 01/2023
1	Enzyme Replacement Therapy 01/2019
1	Secondary Prevention 04/2015
1	Hemodiafiltration 01/2014
1	Renal Dialysis (Hemodialysis) 06/2013
1	Intravenous Injections 12/2012
1	Drug-Eluting Stents 12/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2007
1	Transplantation 08/2007